WO2010090471A3 - 제1형 당뇨병의 신규한 진단 마커 - Google Patents

제1형 당뇨병의 신규한 진단 마커 Download PDF

Info

Publication number
WO2010090471A3
WO2010090471A3 PCT/KR2010/000710 KR2010000710W WO2010090471A3 WO 2010090471 A3 WO2010090471 A3 WO 2010090471A3 KR 2010000710 W KR2010000710 W KR 2010000710W WO 2010090471 A3 WO2010090471 A3 WO 2010090471A3
Authority
WO
WIPO (PCT)
Prior art keywords
type
diabetes mellitus
trna synthetase
diagnosis
antibodies
Prior art date
Application number
PCT/KR2010/000710
Other languages
English (en)
French (fr)
Other versions
WO2010090471A2 (ko
WO2010090471A9 (ko
Inventor
박상규
박경수
김성훈
Original Assignee
서울대학교병원
서울대학교산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 서울대학교병원, 서울대학교산학협력단 filed Critical 서울대학교병원
Priority to JP2011549067A priority Critical patent/JP5571696B2/ja
Priority to EP10738755.7A priority patent/EP2395100B1/en
Priority to CN2010800067618A priority patent/CN102308002A/zh
Publication of WO2010090471A2 publication Critical patent/WO2010090471A2/ko
Publication of WO2010090471A3 publication Critical patent/WO2010090471A3/ko
Publication of WO2010090471A9 publication Critical patent/WO2010090471A9/ko
Priority to US13/198,990 priority patent/US8563327B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/25—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving enzymes not classifiable in groups C12Q1/26 - C12Q1/66
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/105831—Protein or peptide standard or control [e.g., hemoglobin, etc.]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

본 발명은 제1형 당뇨병의 신규한 진단 마커에 관한 것으로, 아미노아실 tRNA 합성효소 또는 이에 대한 항체를 유효성분으로 포함하는 제1형 당뇨병의 진단용 조성물, 아미노아실 tRNA 합성효소의 제1형 당뇨병 진단용 제제의 제조를 위한 용도 및 개체의 시료로부터 항-알라닌 tRNA 합성효소 항체, 항-글리신 tRNA 합성효소 항체, 항-아스파라긴 tRNA 합성효소 항체 및 항-트립토판 tRNA 합성효소 항체를 검출하는 제1형 당뇨병 진단 방법에 관한 것이다. 본 발명의 조성물, 키트 및 방법은 환자의 시료로부터 손쉽게 제1형 당뇨병 여부를 진단할 수 있으므로 제1형 당뇨병의 조기 진단 및 확정을 위하여 사용할 수 있다.
PCT/KR2010/000710 2009-02-05 2010-02-05 제1형 당뇨병의 신규한 진단 마커 WO2010090471A2 (ko)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2011549067A JP5571696B2 (ja) 2009-02-05 2010-02-05 第１型糖尿病の新規な診断マーカー
EP10738755.7A EP2395100B1 (en) 2009-02-05 2010-02-05 Novel diagnostic marker for type 1 diabetes mellitus
CN2010800067618A CN102308002A (zh) 2009-02-05 2010-02-05 第一型糖尿病的新型诊断标志物
US13/198,990 US8563327B2 (en) 2009-02-05 2011-08-05 Diagnostic marker for type 1 diabetes mellitus

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2009-0009231 2009-02-05
KR1020090009231A KR101067815B1 (ko) 2009-02-05 2009-02-05 제1형 당뇨병의 신규한 진단 마커

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13/198,990 Continuation US8563327B2 (en) 2009-02-05 2011-08-05 Diagnostic marker for type 1 diabetes mellitus

Publications (3)

Publication Number Publication Date
WO2010090471A2 WO2010090471A2 (ko) 2010-08-12
WO2010090471A3 true WO2010090471A3 (ko) 2010-11-18
WO2010090471A9 WO2010090471A9 (ko) 2011-01-06

Family

ID=42542522

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2010/000710 WO2010090471A2 (ko) 2009-02-05 2010-02-05 제1형 당뇨병의 신규한 진단 마커

Country Status (6)

Country Link
US (1) US8563327B2 (ko)
EP (1) EP2395100B1 (ko)
JP (1) JP5571696B2 (ko)
KR (1) KR101067815B1 (ko)
CN (1) CN102308002A (ko)
WO (1) WO2010090471A2 (ko)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8835387B2 (en) 2012-02-16 2014-09-16 Atyr Pharma, Inc. Histidyl-tRNA synthetases for treating autoimmune and inflammatory diseases
US9034598B2 (en) 2010-05-17 2015-05-19 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-tRNA synthetases
US9322009B2 (en) 2010-06-01 2016-04-26 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Lysyl-tRNA synthetases
US9528103B2 (en) 2010-04-27 2016-12-27 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl tRNA synthetases
US9593323B2 (en) 2010-05-03 2017-03-14 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-tRNA synthetases

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5771142B2 (ja) * 2008-06-11 2015-08-26 エータイアー ファーマ， インコーポレイテッド チロシル−ｔＲＮＡシンテターゼポリペプチドの血小板新生活性
WO2009158649A1 (en) 2008-06-26 2009-12-30 Atyr Pharma, Inc. Compositions and methods comprising glycyl-trna synthetases having non-canonical biological activities
WO2010099477A2 (en) 2009-02-27 2010-09-02 Atyr Pharma, Inc. Polypeptide structural motifs associated with cell signaling activity
DK3255146T3 (da) 2009-03-16 2019-08-19 Pangu Biopharma Ltd Præparater og fremgangsmåder omfattende histidyl-tRNA-synthetasesplejsningsvarianter med ikke-kanoniske biologiske aktiviteter
US20100310576A1 (en) * 2009-03-31 2010-12-09 Adams Ryan A COMPOSITIONS AND METHODS COMPRISING ASPARTYL-tRNA SYNTHETASES HAVING NON-CANONICAL BIOLOGICAL ACTIVITIES
CA2783731C (en) 2009-12-11 2018-03-27 Atyr Pharma, Inc. Aminoacyl trna synthetases for modulating inflammation
US8828395B2 (en) 2009-12-11 2014-09-09 Atyr Pharma, Inc. Antibodies that bind tyrosyl-tRNA synthetases
US20110150885A1 (en) * 2009-12-11 2011-06-23 Atyr Pharma, Inc. Aminoacyl trna synthetases for modulating hematopoiesis
US8980253B2 (en) 2010-04-26 2015-03-17 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-tRNA synthetase
US8986681B2 (en) 2010-04-27 2015-03-24 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl-tRNA synthetases
AU2011248489B2 (en) 2010-04-28 2016-10-06 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl tRNA synthetases
EP2563383B1 (en) 2010-04-29 2017-03-01 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases
CN103097523B (zh) 2010-04-29 2016-09-28 Atyr医药公司 与天冬酰胺酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
WO2011150279A2 (en) 2010-05-27 2011-12-01 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-trna synthetases
CA2797277C (en) 2010-05-03 2021-02-23 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of arginyl-trna synthetases
CN103108655B (zh) 2010-05-03 2017-04-05 Atyr 医药公司 与丝氨酰‑tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
EP2566496B1 (en) 2010-05-03 2018-02-28 aTyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-trna synthetases
CA2798139C (en) 2010-05-04 2019-09-24 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-trna synthetase complex
CA2798301C (en) 2010-05-04 2020-09-15 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutamyl-prolyl-trna synthetases
CN103200953B (zh) 2010-05-14 2017-02-15 Atyr 医药公司 与苯丙氨酰‑β‑tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
KR20130102534A (ko) 2010-07-12 2013-09-17 에이티와이알 파마, 인코포레이티드 히스티딜­trna 합성효소의 단백질 단편에 관련된 치료적, 진단적, 및 항체 조성물의 혁신적 발견
NZ603811A (en) 2010-07-12 2015-03-27 Atyr Pharma Inc Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of aspartyl-trna synthetases
US8999321B2 (en) 2010-07-12 2015-04-07 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases
EP2593125B1 (en) 2010-07-12 2017-11-01 aTyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases
CN103108650A (zh) 2010-08-25 2013-05-15 Atyr医药公司 与酪氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
CA2812795C (en) 2010-10-06 2021-08-31 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related protein fragments of tryptophanyl trna synthetases
US9714419B2 (en) 2011-08-09 2017-07-25 Atyr Pharma, Inc. PEGylated tyrosyl-tRNA synthetase polypeptides
US9816084B2 (en) 2011-12-06 2017-11-14 Atyr Pharma, Inc. Aspartyl-tRNA synthetases
US9822353B2 (en) 2011-12-06 2017-11-21 Atyr Pharma, Inc. PEGylated aspartyl-tRNA synthetase polypeptides
CA2858613A1 (en) 2011-12-29 2013-08-08 Atyr Pharma, Inc. Aspartyl-trna synthetase-fc conjugates
EP2836845B1 (en) 2012-04-13 2018-05-09 DiabetOmics, Inc. Maternal biomarkers for gestational diabetes
AU2014233436B2 (en) 2013-03-15 2019-12-05 Atyr Pharma, Inc. Histidyl-tRNA synthetase-Fc conjugates
US10027606B2 (en) 2013-04-17 2018-07-17 Nokia Technologies Oy Method and apparatus for determining a notification representation indicative of a cognitive load
CN103630692B (zh) * 2013-06-02 2015-05-06 马鞍山国声生物技术有限公司 快速检测尿液c肽的胶体金免疫层析试剂盒及其检测方法
KR20170027258A (ko) * 2015-09-01 2017-03-09 제이더블유바이오사이언스 주식회사 트립토파닐 티알엔에이 합성효소를 이용한 패혈증의 진단용 조성물과 진단 마커 검출 방법
CN105543400B (zh) * 2016-02-29 2018-12-25 北京泱深生物信息技术有限公司 I型糖尿病的分子标志物
JP2020517638A (ja) 2017-04-20 2020-06-18 エータイアー ファーマ， インコーポレイテッド 肺の炎症を治療するための組成物および方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050118151A1 (en) * 2001-05-29 2005-06-02 Syddansk Universitet Proteins in diabetes proteome anlysis
US20060073134A1 (en) * 2002-03-20 2006-04-06 Syddansk Universitet Human diabetes-mediating proteins

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629188A (en) * 1995-04-21 1997-05-13 Cubist Pharmaceuticals, Inc. Human alanyl-tRNA synthetase proteins, nucleic acids and tester strains comprising same
US6245539B1 (en) * 1998-10-06 2001-06-12 Board Of Trustees Operating Michigan State University Human asparaginyl-tRNA synthetase DNA
JP2006517533A (ja) * 2003-01-23 2006-07-27 ロランティス リミテッド Ｎｏｔｃｈシグナル伝達経路のアクチベーターを用いる自己免疫疾患の治療
EP1718327B1 (en) * 2003-06-20 2015-01-07 University of Florida Biomarkers for differentiating between type 1 and type 2 diabetes
MX2007010349A (es) * 2005-02-24 2008-04-09 Cemines Inc Composiciones y metodos para clasificar muestras biologicas.
EP1989554A1 (en) * 2006-02-06 2008-11-12 Rappaport Family Institute For Research in the Medical Sciences Methods and kit for diagnosing t1dm

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050118151A1 (en) * 2001-05-29 2005-06-02 Syddansk Universitet Proteins in diabetes proteome anlysis
US20060073134A1 (en) * 2002-03-20 2006-04-06 Syddansk Universitet Human diabetes-mediating proteins

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
LERNMARK: "Autoimmune diseases.", J. CLIN. INVEST., vol. 108, no. 8, October 2001 (2001-10-01), pages 1091 - 1096 *
PARK ET AL.: "Aminoacyl tRNA synthetases and their connections to disease.", PNAS, vol. 105, no. 32, August 2008 (2008-08-01), pages 11043 - 11049, XP008145929 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9528103B2 (en) 2010-04-27 2016-12-27 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl tRNA synthetases
US9593323B2 (en) 2010-05-03 2017-03-14 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-tRNA synthetases
US9034598B2 (en) 2010-05-17 2015-05-19 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-tRNA synthetases
US9322009B2 (en) 2010-06-01 2016-04-26 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Lysyl-tRNA synthetases
US8835387B2 (en) 2012-02-16 2014-09-16 Atyr Pharma, Inc. Histidyl-tRNA synthetases for treating autoimmune and inflammatory diseases

Also Published As

Publication number Publication date
KR20100090003A (ko) 2010-08-13
CN102308002A (zh) 2012-01-04
WO2010090471A2 (ko) 2010-08-12
US8563327B2 (en) 2013-10-22
JP2012517014A (ja) 2012-07-26
US20120015383A1 (en) 2012-01-19
EP2395100B1 (en) 2014-09-17
JP5571696B2 (ja) 2014-08-13
KR101067815B1 (ko) 2011-09-27
EP2395100A2 (en) 2011-12-14
EP2395100A4 (en) 2012-08-01
WO2010090471A9 (ko) 2011-01-06

Similar Documents

Publication Publication Date Title
WO2010090471A3 (ko) 제1형 당뇨병의 신규한 진단 마커
WO2010041892A3 (ko) Aimp1 폴리펩티드의 신규한 용도
WO2008070865A3 (en) Materials and methods for efficient and accurate detection of analytes
WO2006090389A3 (en) Novel diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof
WO2009113814A3 (ko) 간암 진단용 단백질성 마커
WO2008057437A3 (en) Ex vivo flow cytometry method and device
WO2007092627A3 (en) Detection of cancer by elevated levels of bcl-2
NZ602056A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2010039809A3 (en) Primers and probes for detecting human papillomavirus and human beta globin sequences in test samples
WO2010141075A8 (en) Specific analysis of ketone and aldehyde analytes using reagent compounds, labeling strategies, and mass spectrometry workflow
WO2014074835A3 (en) Antibody compositions and immunoassay methods to detect isoforms of anti-mullerian hormone
WO2006117689A3 (en) Method for diagnosing multiple sclerosis
WO2006132797A3 (en) Preparation of small liquid samples for automated analysis
WO2008111464A1 (ja) スプライシング異常を指標とする抗ガン剤の作用検定方法
WO2007114986A3 (en) Cooperative probes and methods of using them
WO2008122670A3 (en) Human diabetes susceptibility tnfrsf10b gene
WO2012141554A8 (ko) 접합 물질과 코티닌과의 접합체에 항-코티닌 항체가 결합된 복합체 및 이의 용도
WO2006092729A3 (en) Novel biomarkers for diagnosis and/or prognosis or prognosis of neoplasias in animals
WO2010092164A3 (en) Bacterial dna as markers of cardiovascular and/or metabolic disease
WO2011015602A3 (en) Lung cancer biomarkers
HK1133295A1 (en) Use of protein s100a12 as a marker for colorectal cancer s100a12
WO2009007846A3 (en) Methods for modifying, isolating, detecting, visualizing, and quantifying citrullinated and/or homocitrullinated peptides, polypeptides and proteins
EP1898215A4 (en) METHOD FOR ANALYZING ENDOCRINE SUBSTANCE IN A SPECIMEN
WO2005124356A3 (en) Use of protein cbp2 as a marker for colorectal cancer
EP2081029A3 (en) Bio-markers for diagnosing diabetic retinopathy

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201080006761.8

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10738755

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2011549067

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2010738755

Country of ref document: EP